Cargando…

Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies

Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor, progesterone receptor, or human epidermal growth factor receptor-2, affects nearly 15% of women with breast cancer. To date, the mainstay of treatment remains chemotherapy, with all the associated consequences,...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kanwal, Bushra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384383/ https://www.ncbi.nlm.nih.gov/pubmed/34458041 http://dx.doi.org/10.7759/cureus.16636

Ejemplares similares

Leptomeningeal Carcinomatosis: A Case Report of Metastatic Triple-negative Breast Adenocarcinoma
por: Parker, Nathaniel, et al.
Publicado: (2019)

Role of Immunotherapy in the Treatment of Triple-Negative Breast Cancer: A Literature Review
por: K Patel, Khushbu, et al.
Publicado: (2022)

Relapsed/Refractory Non-Hodgkin Lymphoma: Engineering T-Cells to Express Chimeric Antigen Receptors (CARs), a Salvage?
por: Kanwal, Bushra
Publicado: (2021)

Round Atelectasis: A Peculiar Pseudotumor Seen on Echocardiogram
por: Abdelsayed, Nardine, et al.
Publicado: (2021)

The Feline and the Swine: A Peculiar Case in an Allergy Clinic
por: Kile, Mahlon R, et al.
Publicado: (2023)

Impact of Pathologic Complete Response on the Prognosis of Triple-Negative Breast Cancer Patients: A Cohort Study
por: Assunção Ribeiro da Costa, Rafael Everton, et al.
Publicado: (2023)

Peculiar Presentation of Gastrointestinal Stromal Tumor in a Patient With Early Satiety
por: Obi, Franklin, et al.
Publicado: (2023)

Third Line Eribulin for Triple-negative Metastatic Breast Ductal Carcinoma Resulting in Extended Progression-free Survival of 57 Months
por: Manthri, Sukesh, et al.
Publicado: (2020)

Immunotherapy in Advanced Non-small Cell Lung Cancer Patients: Ushering Chemotherapy Through the Checkpoint Inhibitors?
por: Kanwal, Bushra, et al.
Publicado: (2018)

Frequency and Clinicopathologic Characteristics of Triple-Negative Breast Cancer Among Breast Cancer Patients Presenting to Medical Oncology Department, Hayatabad Medical Complex Peshawar, Pakistan
por: Hussain, Shah, et al.
Publicado: (2023)

Triple-Negative Sjogren’s Syndrome and Recurrent Pneumothorax: An Uncommon Presentation of Autoimmune Disease
por: Imad, Ziryab, et al.
Publicado: (2022)

Triple Threat: Triple Pathogen Endocarditis
por: Gonzalez, Jessica M, et al.
Publicado: (2023)

Unmasking Non-small Cell Lung Cancer: The Unusual Trail of Hip Pain and Skeletal Metastasis
por: Ahmad, Hamad, et al.
Publicado: (2023)

Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets
por: Schubert, Peter, et al.
Publicado: (2018)

Triple Tick Attack
por: Kumar, Manish, et al.
Publicado: (2019)

Awareness and Perception Toward Alzheimer’s Disease Among Residents Living in the Jazan Province, Saudi Arabia: A Cross-Sectional Study
por: Hakami, Faisal, et al.
Publicado: (2023)

Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances
por: Jacks, Boma E, et al.
Publicado: (2022)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

Untangling Peripheral Sympathetic Neurocircuits
por: Clyburn, Courtney, et al.
Publicado: (2022)

Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia
por: Yıldız, Jale, et al.
Publicado: (2022)

Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
por: Soares, Ryan, et al.
Publicado: (2022)

Helicobacter pylori Resistance to Triple Therapy in a Multicultural Population in New York City
por: Fernandez-Perez, Silvia, et al.
Publicado: (2021)

Mechanism-Based Sonodynamic–Chemo Combinations against Triple-Negative Breast Cancer
por: Feng, Xiaolan, et al.
Publicado: (2022)

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
por: Li, Shenduo, et al.
Publicado: (2015)

Libman-Sacks Endocarditis With Triple Valvular Involvement
por: Asher Syed, Meeran, et al.
Publicado: (2023)

Analysis of the Diagnosis of Burkitt-Like Lymphoma in a Patient With Atypical Cytogenetics and Molecular Markers
por: Brunner, Jackson R, et al.
Publicado: (2022)

Angioedema From Triple Therapy: A Case Report
por: Lepore, Nicholas, et al.
Publicado: (2023)

Invasive Lobular Breast Carcinoma Can Be a Challenging Diagnosis Without the Use of Tumor Markers
por: Klumpp, Linda C, et al.
Publicado: (2020)

The Role of Tumor Markers: Carcinoembryonic Antigen and Cancer Antigen 15-3 in Patients With Breast Cancer
por: Khushk, Maimoona, et al.
Publicado: (2021)

Characterization of triple-phase computed tomography in dogs with pancreatic insulinoma
por: FUKUSHIMA, Kenjiro, et al.
Publicado: (2015)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023)

Supernumerary Kidney (Triple Kidney) With Horseshoe Malformation: A Case Report
por: Nimkar, Shubham V, et al.
Publicado: (2022)

Knowledge and Attitude of General Pakistani Population Towards Antibiotic Resistance
por: Akhund, Ramsha, et al.
Publicado: (2019)

Triple Expressor Lymphoma: Presentation With Acute Paraparesis Due to Spinal Cord Compression
por: Alburqueque-Melgarejo, Joseph, et al.
Publicado: (2022)

Triple Pancreatic Walled-off Fluid Collections Treated Simultaneously with Endoscopic Transmural Drainage
por: Khalid, Sameen, et al.
Publicado: (2018)

Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells
por: Mauro-Lizcano, Marta, et al.
Publicado: (2018)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
por: Kundu, Manjari, et al.
Publicado: (2022)

Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability
por: Burley, Nicholas B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_14op7mh3lhobvlbh48js22e3nh